Lys33

Site Information
SVVRRCVkLCTGHEY SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4132021
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 ) , non-small cell lung adenocarcinoma ( 1 ) , small-cell lung cancer ( 2 )
Relevant cell line - cell type - tissue:	DMS153 (pulmonary) ( 1 ) , DMS79 (pulmonary) ( 2 ) , lung ( 1 , 2 ) , NCI-H128 (pulmonary) ( 2 ) , NCI-H1417 (pulmonary) ( 2 ) , NCI-H1437 (pulmonary) ( 1 ) , NCI-H2073 (pulmonary) ( 1 ) , NCI-H209 (pulmonary) ( 1 , 2 ) , NCI-H524 (pulmonary) ( 2 ) , NCI-H838 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20221; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20213; Year: 2013; Biosample/Treatment: cell line, H1417, DMS79, H128, H209, H524; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info